Eftychia Oikonomou

751 total citations
16 papers, 597 citations indexed

About

Eftychia Oikonomou is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Eftychia Oikonomou has authored 16 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Eftychia Oikonomou's work include Cancer-related Molecular Pathways (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cell death mechanisms and regulation (4 papers). Eftychia Oikonomou is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Cell death mechanisms and regulation (4 papers). Eftychia Oikonomou collaborates with scholars based in Greece, United Kingdom and Germany. Eftychia Oikonomou's co-authors include Alexander Pintzas, Ladislav Anděra, Evangelos Koustas, Maria Goulielmaki, Takehiko Sasazuki, Michal Koc, Senji Shirasawa, Eric F. Adams, Michael Buchfelder and Georgios Zografos and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Eftychia Oikonomou

16 papers receiving 587 citations

Peers

Countries citing papers authored by Eftychia Oikonomou

Since Specialization

Citations

This map shows the geographic impact of Eftychia Oikonomou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eftychia Oikonomou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eftychia Oikonomou more than expected).

Fields of papers citing papers by Eftychia Oikonomou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eftychia Oikonomou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eftychia Oikonomou. The network helps show where Eftychia Oikonomou may publish in the future.

Co-authorship network of co-authors of Eftychia Oikonomou

This figure shows the co-authorship network connecting the top 25 collaborators of Eftychia Oikonomou. A scholar is included among the top collaborators of Eftychia Oikonomou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eftychia Oikonomou. Eftychia Oikonomou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Psychiatric Hospital of Leros: a portrayal of the current situation 2023 ·Psychiatriki ·(unknown), (unknown), Eftychia Oikonomou, (unknown), (unknown), G. Moussas	1
2	BRAF associated autophagy exploitation: BRAF and autophagy inhibitors synergise to efficiently overcome resistance of BRAF mutant colorectal cancer cells 2016 ·Oncotarget ·Maria Goulielmaki, Evangelos Koustas, (unknown), (unknown), Takehiko Sasazuki, Senji Shirasawa, George Zografos, Eftychia Oikonomou, Alexander Pintzas	58
3	BRAF vs RAS oncogenes: are mutations of the same pathway equal? differential signalling and therapeutic implications 2014 ·Oncotarget ·Eftychia Oikonomou, Evangelos Koustas, Maria Goulielmaki, Alexander Pintzas	80
4	The TRAIL of oncogenes to apoptosis 2013 ·BioFactors ·Eftychia Oikonomou, Alexander Pintzas	34
5	Tumor Heterogeneity Revealed byKRAS,BRAF, andPIK3CAPyrosequencing:KRASandPIK3CAIntratumor Mutation Profile Differences and Their Therapeutic Implications 2013 ·Human Mutation ·Vivian Kosmidou, Eftychia Oikonomou, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Georgios Zografos, Alexander Pintzas	56
6	A Molecular Signature for Oncogenic BRAF in Human Colon Cancer Cells is Revealed by Microarray Analysis 2012 ·Current Cancer Drug Targets ·(unknown), Eftychia Oikonomou, Vivian Kosmidou, (unknown), Ioannis Bantounas, (unknown), Georgios Zografos, Alexander Pintzas	18
7	BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study 2011 ·Molecular Cancer ·(unknown), Eftychia Oikonomou, Michal Koc, Ladislav Anděra, Takehiko Sasazuki, Senji Shirasawa, Alexander Pintzas	121
8	Selective BRAFV600E Inhibitor PLX4720, Requires TRAIL Assistance to Overcome Oncogenic PIK3CA Resistance 2011 ·PLoS ONE ·Eftychia Oikonomou, Michal Koc, (unknown), Ladislav Anděra, Alexander Pintzas	34
9	TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors 2009 ·International Journal of Cancer ·Eftychia Oikonomou, Vivian Kosmidou, (unknown), (unknown), (unknown), George Kontogeorgos, Ladislav Anděra, Georgios Zografos, Alexander Pintzas	17
10	BRAFV600E Efficient Transformation and Induction of Microsatellite Instability Versus KRASG12V Induction of Senescence Markers in Human Colon Cancer Cells 2009 ·Neoplasia ·Eftychia Oikonomou, (unknown), (unknown), (unknown), Lesley Probert, Alexander Pintzas	36
11	Cholecystokinin (CCK) and CCK receptor expression by human gliomas: Evidence for an autocrine/paracrine stimulatory loop 2008 ·Neuropeptides ·Eftychia Oikonomou, Michael Buchfelder, Eric F. Adams	19
12	Newly established tumourigenic primary human colon cancer cell lines are sensitive to TRAIL-induced apoptosis in vitro and in vivo 2007 ·British Journal of Cancer ·Eftychia Oikonomou, (unknown), (unknown), George Nasioulas, Ladislav Anděra, (unknown)	31
13	Cancer genetics of sporadic colorectal cancer: BRAF and PI3KCA mutations, their impact on signaling and novel targeted therapies. 2006 ·PubMed ·Eftychia Oikonomou, (unknown)	24
14	β-catenin mutations in craniopharyngiomas and pituitary adenomas 2005 ·Journal of Neuro-Oncology ·Eftychia Oikonomou, (unknown), Beatriz Santana Soares, Luiz Marco, Michael Buchfelder, Eric F. Adams	62
15	Meningiomas expressing and responding to cholecystokinin (CCK) 2005 ·Journal of Neuro-Oncology ·Eftychia Oikonomou, (unknown), Michael Buchfelder, Eric F. Adams	2
16	A polymorphism in the growth hormone-releasing hormone receptor gene: Clinical significance? 2002 ·Regulatory Peptides ·Eric F. Adams, Eftychia Oikonomou, (unknown), Michael Buchfelder, Rosalind Mitchell, David R. Poyner	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact